Probiotics: an update

Journal Title: Jornal de Pediatria - Year 2015, Vol 91, Issue 1

Abstract

Objective Triggered by the growing knowledge on the link between the intestinal microbiome and human health, the interest in probiotics is ever increasing. The authors aimed to review the recent literature on probiotics, from definitions to clinical benefits, with emphasis on children. Sources Relevant literature from searches of PubMed, CINAHL, and recent consensus statements were reviewed. Summary of the findings While a balanced microbiome is related to health, an imbalanced microbiome or dysbiosis is related to many health problems both within the gastro-intestinal tract, such as diarrhea and inflammatory bowel disease, and outside the gastro-intestinal tract such as obesity and allergy. In this context, a strict regulation of probiotics with health claims is urgent, because the vast majority of these products are commercialized as food (supplements), claiming health benefits that are often not substantiated with clinically relevant evidence. The major indications of probiotics are in the area of the prevention and treatment of gastro-intestinal related disorders, but more data has become available on extra-intestinal indications. At least two published randomized controlled trials with the commercialized probiotic product in the claimed indication are a minimal condition before a claim can be sustained. Today, Lactobacillus rhamnosus GG and Saccharomyces boulardii are the best-studied strains. Although adverse effects have sporadically been reported, these probiotics can be considered as safe. Conclusions Although regulation is improving, more stringent definitions are still required. Evidence of clinical benefit is accumulating, although still missing in many areas. Misuse and use of products that have not been validated constitute potential drawbacks.

Authors and Affiliations

Yvan Vandenplas

Keywords

Related Articles

Trp64Arg polymorphism of the ADRB3 gene associated with maximal fat oxidation and LDL-C levels in non-obese adolescents

Objective To analyze the association between the Trp64Arg polymorphism of the ADRB3 gene, maximal fat oxidation rates and the lipid profile levels in non-obese adolescents. Methods 72 schoolchildren, of both genders, ag...

T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome

Objective There is evidence of an important role of immune system changes in the triggering and maintenance of idiopathic nephrotic syndrome (INS). The aim of this study was to investigate the expression of cytokines in...

Risk factors for candidemia mortality in hospitalized children

Objective To evaluate risk factors associated with death due to bloodstream infection caused by Candida spp. in pediatric patients and evaluate the resistance to the main anti-fungal used in clinical practice. Methods T...

Antibody persistence following meningococcal C conjugate vaccination in children and adolescents infected with human immunodeficiency virus

Objective HIV-infected individuals (HIVI) are threatened by meningococcal infection and presented lower response to vaccines. Data are scarce on long-term persistence of human serum bactericidal antibody (hSBA) after a m...

Genetic determinants and stroke in children with sickle cell disease

Objective To verify genetic determinants associated with stroke in children with sickle cell disease (SCD). Methods Prospective cohort with 110 children submitted to neonatal screening by the Neonatal Screening Program,...

Download PDF file
  • EP ID EP561096
  • DOI 10.1016/j.jped.2014.08.005
  • Views 50
  • Downloads 0

How To Cite

Yvan Vandenplas (2015). Probiotics: an update. Jornal de Pediatria, 91(1), 6-21. https://europub.co.uk/articles/-A-561096